ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 69 filers reported holding ALBIREO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,829 | -99.9% | 269,731 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $5,122,000 | -33.7% | 264,536 | -32.0% | 0.00% | -33.3% |
| Q2 2022 | $7,722,000 | -28.3% | 388,857 | +7.7% | 0.00% | 0.0% |
| Q1 2022 | $10,771,000 | +41.6% | 361,061 | +10.6% | 0.00% | +50.0% |
| Q4 2021 | $7,606,000 | -22.2% | 326,575 | +4.2% | 0.00% | -33.3% |
| Q3 2021 | $9,780,000 | -27.8% | 313,468 | -18.6% | 0.00% | -25.0% |
| Q2 2021 | $13,548,000 | +8.9% | 385,094 | +9.1% | 0.00% | 0.0% |
| Q1 2021 | $12,445,000 | +15.0% | 353,043 | +22.4% | 0.00% | 0.0% |
| Q4 2020 | $10,820,000 | +30.9% | 288,436 | +16.4% | 0.00% | 0.0% |
| Q3 2020 | $8,266,000 | +27.8% | 247,720 | +1.5% | 0.00% | +33.3% |
| Q2 2020 | $6,466,000 | +68.1% | 244,088 | +3.9% | 0.00% | +50.0% |
| Q1 2020 | $3,847,000 | -30.8% | 234,992 | +7.5% | 0.00% | 0.0% |
| Q4 2019 | $5,558,000 | +28.7% | 218,668 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $4,320,000 | -35.7% | 215,942 | +3.6% | 0.00% | -33.3% |
| Q2 2019 | $6,719,000 | +30.6% | 208,400 | +30.5% | 0.00% | +50.0% |
| Q1 2019 | $5,143,000 | +80.5% | 159,690 | +37.4% | 0.00% | +100.0% |
| Q4 2018 | $2,850,000 | +4.4% | 116,223 | +40.3% | 0.00% | 0.0% |
| Q3 2018 | $2,730,000 | +473.5% | 82,833 | +518.1% | 0.00% | – |
| Q2 2018 | $476,000 | – | 13,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |